Francis Medical has obtained $80 million in venture capital funding to support the development of its water vapor ablation therapy for cancers of the prostate, kidneys and bladder. The series C round ...

Add Yahoo as a preferred source to see more of our stories on Google. Francis Medical’s Vanquish device for treating intermediate-risk prostate cancer has been cleared by the US Food and Drug ...

Francis Medical, Inc., a privately held medical device company, today announced the continued expansion of its U.S.

MINNEAPOLIS, March 25, 2026 /PRNewswire/ -- Francis Medical, Inc., a privately held medical device company, announced today the successful completion of the first commercial (non-clinical study) ...

MINNEAPOLIS, March 5, 2026 /PRNewswire/ -- Francis Medical, Inc., a privately held medical device company, announced today the successful completion of the first commercial (non-clinical trial) ...

Maple Grove. Minn.-based Francis Medical has announced that Aaron Milbank, MD, performed the first commercial procedure in the Midwest using its Vanquish Water Vapor Ablation System at High Pointe ...

Francis Medical, Inc., a privately held medical device company based in Maple Grove, Minn., today announced that Aaron ...

MINNEAPOLIS, Dec. 2, 2025 /PRNewswire/ -- Francis Medical, Inc., a privately-held medical device company developing the breakthrough Vanquish® Water Vapor Ablation System for the management of ...

Before having Aquablation (water ablation) therapy, it is essential to check that the treatment, equipment, medical facility, and healthcare professional are Medicare-approved and that the person ...

Francis Medical announces commercial expansion of Vanquish Water Vapor Ablation with first commercial procedures to ablate targeted prostate tissue in Southeast: Minneapolis, Minn ...